- This episode is a biohacking roundtable hosted by Chris Williamson featuring Ben Greenfield, Dr. Gabrielle Lyon, and others discussing peptide protocols, GLP-1 agonists, experimental devices, stem cell breakthroughs, testosterone therapy, regulatory battles, plasmapheresis, longevity biomarkers, nutrition debates, environmental toxins, and emerging health frontiers.
Peptide Regimens & GLP-1 Deep Dive
- Participants share personal peptide stacks used as “condiments” atop foundational lifestyle principles.
- Ben Greenfield: thymosin alpha-1 for travel immunity, BPC-157/TB-500 for injuries, tesamorelin/ipamorelin/CJC-1295 cycles for growth hormone, Cmax (cognition/BDNF) and Cank (anxiolytic) intranasal.
- Gabrielle Lyon: adds IGF-1 LR3 (insulin-like growth factor long R3) for growth hormone benefits without suppressing endogenous GH; cycles 4–6 weeks on, then switches to CJC/ipamorelin to boost natural GH.
- Chris Williamson: microdoses GLP-1 (≈0.25 mg vs standard 1–2 mg) occasionally for inflammation and “food noise” suppression on travel days.
- GLP-1 microdosing for inflammation is an emerging clinical observation; the discoverer of GLP-1’s appetite effect (Arne Astrup) believes low-dose anti-inflammatory effects may reduce cancer risk independent of weight loss.
- Mechanism unclear: could be reduced food turnover, lower obesity-driven inflammation, or direct anti-inflammatory signaling.
- Clinicians report anecdotal inflammation reduction in 70,000+ patients at microdoses far below insurance-covered thresholds.
- Sarcopenia is the looming second-order crisis: GLP-1s enable rapid weight loss magnitudes previously only seen with bariatric surgery, but without concurrent resistance training and adequate protein, patients lose muscle mass and bone density.
- “We are at the precipice of trading obesity for sarcopenia” — frailty becomes the new epidemic.
- Muscle quality (intramuscular triglyceride reduction) may improve on GLP-1s even if DEXA shows lean mass loss; DEXA cannot distinguish muscle from intramuscular fat loss.
- Sexual side effects differ by sex: men often see increased testosterone, lower estrogen, higher libido; women report decreased libido via central dopamine/reward pathway suppression (same mechanism being studied for addiction).
- Insurance models force patients into higher, trial-based doses (studied in morbidly obese/diabetic populations) rather than efficacious microdoses, exacerbating muscle loss and side effects.
- Compounding pharmacies offer dose flexibility, but insurance follows labeled indications, creating misalignment for non-obese users.
Experimental Devices & Modalities
- BioCharger: Tesla coil with 12 noble gas tubes emitting radio frequencies and red light; anecdotal libido/energy benefits, zero clinical data; Chris tried for a month, noticed nothing.
- Windback / Tecar therapy: high-frequency radio wave device with patches for tissue healing; localizes to pain sites; limited US data but users report subjective improvement.
- Roxiva lamp (Rocca): vibroacoustic bed + flickering light + headphones for light-sound entrainment; sessions range from 5–60 min, including “Rebirth” (womb sounds, fetal heartbeat) producing profound state shifts and post-session adrenaline dump; Chris found it powerful.
- Mechanism: brainwave entrainment via light/sound/vibration; similar to Shiftwave but adds photic stimulation.
- Steven Porges’ Safe and Sound Protocol uses similar maternal vocal frequency bands across humans, dogs, horses for nervous system re-entrainment.
- Hyperbaric oxygen (2.2 ATA, 90 min, 20 min on/5 off): described as “better than any coffee, cold plunge, anything” for cognitive clarity and energy; parasympathetic activation from pressure depth.
- Hydrogen baths & inhalation: transdermal/inhaled molecular hydrogen as selective antioxidant (donates/accepts electrons without blunting exercise hormesis); inhalation achieves highest tissue concentration; Alex Tarnava’s machine praised by hydrogen researcher Tyler LeBaron; baths used for relaxation + reading.
MUSE Stem Cells: Breakthrough & Access
- MUSE (Multi-lineage Stress Enduring) cells discovered 2014 by Mari Dezawa (Japan): rare subset (<2% of MSCs) surviving days at room temperature, crossing blood-brain barrier, 30% engraftment vs 3% for MSCs, engraft within 48h, immunomodulatory (high histocompatibility).
- Via phagocytosis, they consume damaged cells and adopt their phenotype (e.g., become healthy neurons).
- Japan RCT: IV MUSE cells in newborns with encephalitis → 90% normal brain function at 2 years vs near-universal damage in controls.
- Case: heart transplant candidate removed from list after IV MUSE treatment showed cardiac recovery.
- Sourced from discarded placental tissue (healthy C-section births); Texas “Right to Try” law enables access; Florida, Tennessee, Utah passing similar laws; Arizona bill vetoed.
- Not FDA-approved; all off-label, cash-pay; clinicians argue for medical freedom under clinician supervision vs forced gray/black markets.
Heat, Cold & Heat Shock Proteins
- Heat shock proteins (HSPs) require core temperature elevation; Brian Johnson data: 30 min at 200°F needed for HSP response (leaner bodies need more heat/longer duration).
- Paradox: sauna reduces dementia risk, but cranial overheating >200°F without wool cap increases risk.
- Weight training produces HSP elevation comparable to sauna; cold plunging also upregulates HSPs via thermoregulatory stress.
- Cold plunge timing: ≥10 min at true cold temps needed to drop muscle temp 1°C and blunt anabolic response; 3-min plunges post-workout likely fine.
- Hydrogen and methylene blue are selective antioxidants acceptable post-exercise without blunting adaptation.
Resonance Breathing & Nervous System Regulation
- M. Health lamp (Jay Wiles): FDA-registered HRV sensor in stone; vibratory/visual pacing at 5.5s in / 5.5s out (universal resonance frequency for peak HRV/vagal tone).
- Usable while watching TV or lying in bed; 10–20 min sessions, 3–4x/week shift trait (not just state) HRV.
- Chris: “clock and bell” MP3 (tick-tock-ding) trained subconscious resonance breathing during work.
Testosterone: Science, Stigma & Clinical Reality
- Historical demonization from 1930s Huggins study (n=3, castration for prostate cancer); debunked in 1990s by Morgentaler — testosterone does not cause prostate cancer or CVD; low T increases all-cause mortality, metabolic disease, depression, osteoporosis.
- Receptor saturation model: physiologic T fills receptors; supraphysiologic doses cause side effects (aromatization → estrogen/gyno, DHT → baldness); replacement ≠ enhancement.
- SHBG (sex hormone binding globulin) rises in perceived famine/stress (low carb, high cortisol, birth control), lowering free T; lifestyle fixes (carbs at dinner, sleep, stress reduction) often lower SHBG.
- Fertility preservation: hCG, clomiphene, sperm banking (cheap for men) allow TRT without permanent infertility; 10% baseline male infertility.
- War fighter screening memo (Pete Hegseth): screen for hypogonadism, treat to physiologic levels — not enhancement — for readiness; women also included.
- Cultural stigma: testosterone = “steroids/cheating”; GLP-1 = “health/weight loss”; both are pharmacologic tools, but male-coded agency vs female-coded aesthetics drives double standard.
- Women on GLP-1s lose weight, hormones drop (estrogen, testosterone), but testosterone replacement is shamed as “juicing,” creating skinny-fat rebound cycle.
The FDA Peptide Ban & Regulatory Fight
- FDA Category 2/3 bulk substance list (2023) banned compounding of 17 peptides (BPC-157, TB-500, etc.) overnight with no safety data, no adverse event reports, no notice.
- Compounding pharmacies (503A/B) legally provided patient-specific, board-inspected products; ban created gray/black markets (Florida indictment: Chinese API tainted with testosterone).
- Industry submitted 800+ studies, 5,000 pages, 16M-patient retrospective analysis (BPC-157: 3 adverse events) to FDA advisory committee.
- FDA released misleading statement using black-market API data; clinicians voted 6/7 peptides safe, FDA voted straight-line against.
- Core conflict: FDA demands IND/new drug pathway (billions, years, patent moat); peptides are natural, unpatentable; compounding protected by 1997 FDAMA.
- Eisenhower’s “scientific-industrial complex” warning cited: industry monetizes chronic disease (avg American on 4+ Rx, sickest developed nation).
- Right-to-Try legislation (Texas, federal) seeks patient/clinician freedom for terminal/chronic conditions; cash-pay model bypasses insurance/PBM rebate distortions.
Plasmapheresis & Advanced Filtration
- Therapeutic plasma exchange (TPE): blood removed, plasma filtered, replaced with albumin (or stem cell/exosome “soup”); “oil change for the body.”
- Filters: heparin-coated for spike protein (long COVID), marker filter for microplastics, lipid apheresis for Lp(a)/ApoB.
- 24h immune suppression post-procedure (avoid flights/crowds); immune rebound + inflammation clearance after.
- RCT: 18-month biological age reversal in >50yo; used decades in hospitals for myasthenia gravis, toxin exposure, burn victims.
- Jelly Roll (250 lb weight loss): plasma exchange resolved residual inflammation/sleep issues unaddressed by sauna/sweat (microplastics >100 Daltons too large for sweat glands).
- CCTA (coronary CT angiography) with AI: visualizes soft vs hard plaque; lipid panels miss deposition (good lipids ≠ clean arteries); guides statin/PCSK9 vs enzyme (nattokinase, lumbrokinase, cyclodextrin) decisions.
- Full-body MRI: early detection (cancer stage 0, 7y advance via Grail test); can cause anxiety (incidental findings); requires clinician context.
Core Longevity Levers (Free & Measurable)
- Muscle mass > VO2 max for frailty prevention; strength training improves BP/cardiovascular health; VO2 max reflects cardiovascular health but not necessarily causal for longevity.
- Grip strength: proxy for heavy lifting/manual labor, not hand-squeezing.
- Walking speed: cadence slightly faster than default; counterpace device syncs footstrike to diastolic phase (resonance walking).
- 7,000–8,000 steps/day at brisk pace; VO2 max bursts (10–20s, 3–5x/week) effective per new data.
Protein, Fiber & Gut Individuality
- Protein Working Group (100 top researchers): sweet spot 1.2–1.6 g/kg (not 1 g/lb); no human aging data supports protein restriction/autophagy cycling; turnover 250–300g/day declines with age.
- Protein prioritization = satiety/caloric displacement (steak stops overeating).
- Fiber: highly individual; high-FODMAP foods (inulin, chicory, garlic, onions, apples) wreck SIBO/diverticulitis/IBS patients; low-FODMAP + chia/nuts/seeds/cooked greens often tolerated.
- Test don’t guess: GI-MAP stool, Trio-Smart SIBO breath, FoodMarble at-home; or 4-week elimination/reintroduction tracked via app/Claude.
- Bloating often from rushed/stressed eating (low enzymes, slowed gastric emptying) not fiber itself.
Personal Diet Patterns
- Ben Greenfield: paleo-ish + fermented veg (kimchi/sauerkraut), underground storage organs (sweet potato, yam), berries, honey, wild game, clean farmed fish (Kvarøy/CTopia), pastured meat, dessert = CocoJune coconut yogurt + blueberries + dark chocolate + macadamia/Brazil nuts.
- Gabrielle Lyon: Forever Strong playbook — high protein, high-fat dairy, fermented foods, sweet potato/rice, minimal ultra-processed.
- Chris: protein-first, simple, avoids decision fatigue.
Fasting Protocols & Sex Differences
- Daily 12–16h overnight fast (men 12–16h, premenopausal women ≤12h to protect kisspeptin/LH/FSH/fertility; postmenopausal women 12–16h).
- Monthly 24h dinner-to-dinner fast; quarterly 3–5 day fasting-mimicking diet (low protein/calories) for autophagy.
-
18h fasting triggers cellular autophagy; compressed window mainly aids calorie control until that threshold.
Diagnostics: What’s Worth It vs Waste
- MTHFR: not necessary; just use methylated B vitamins empirically.
- Lipid panel myopia: LDL/HDL/trigs/Lp(a)/ApoB are clues, not plaque truth; CCTA + AI imaging is gold standard (≈$1,000, radiation, software version drift).
- Carotid IMT ultrasound (5 min, no radiation) correlates up to 97% with CCTA in some datasets; good screening proxy.
- DEXA misses muscle quality (intramuscular fat); whole-body MRI or emerging water-based frequency imaging needed for insulin resistance correlation.
- Baseline testing by 40: hormones, CCTA, DEXA, VO2 max → AI mortality modeling.
Microplastics: Exposure, Detection & Policy
- #1 source: oral exposure via food packaging (ubiquitous); lip gloss (girls 6–8yo, high lip vascular absorption); nitrile gloves contaminate lab studies (sterates mimic microplastics).
- Chewing gum microplastics too large for gut absorption; clothing (Lululemon) less impactful than food packaging.
- Texas exploring labeling mandates; 2–3 large states can force national label changes.
Emerging Frontiers: Anabolics, Gene Therapy, Social Media
- Anabolic agents (nandrolone, oxandrolone) for sarcopenia/cartilage repair: nandrolone improves bone mineral density; oxandrolone lowers SHBG → raises free T.
- Follistatin gene therapy (Minicircle, Roatán, Honduras): AAV upregulates endogenous follistatin → +10 lb muscle in 3 months without diet/training changes; not reversible (initially claimed reversible); $25k+; IntellxxDNA genetic testing guides candidacy.
- Social media = “tobacco of our time” for youth neurodevelopment; anabolics = next major clinical trend.
EMF Mitigation Strategies
- Bluetooth (Class 3): minimal data for harm; wired headphones = Pascal’s Wager.
- Wi-Fi/5G: proximity matters — keep router far from bedroom; neighbor signals negligible.
- Tesla: back seat near battery exceeds safety limits; shielding fabric available but hard to install professionally.
- Bedroom: Faraday paint, shielded Ethernet, grounded floors, no Wi-Fi, EMF-blocking canopy/sheets; Eight Sleep control unit emits more than pad — some Faraday cage the tower.
- Phone: low bar = high RF output; airplane mode or distance during plane landing (100 phones searching = high exposure).
Air Quality, Mold & Environmental Health
- Ideal HVAC: MERV filter (PM2.5/PM10) + UV/ozone scrubber (duct mold) + fresh air recirculator; Jasper standalone units as retrofit.
- Cooking generates massive PM2.5; kitchen needs dedicated HEPA.
- Mold: genetic susceptibility (HLA-DR, glutathione pathways) explains why housemates diverge; week-long exposure can trigger chronic illness in susceptible; Shoemaker protocol + binders + sauna; Mold Co systematizes testing/treatment (potential conflict of interest noted).
- Book: Prescription for a Healthy Home (building materials, carpets, paint, roofing).
Genetic Testing & Follistatin Gene Therapy
- IntellxxDNA: once-in-lifetime genomic panel (detox, methylation, neurotransmitter, etc.); requires clinician; Function Health releasing consumer version.
- Follistatin gene therapy: not CRISPR editing; upregulates existing gene; Chris gained 10 lb muscle/3 months; irreversible; repeat needed every 1–1.5y; company now discloses non-reversibility.
Where to Find Participants
- Ways2Well.com (peptide access, clinical services)
- DrGabrielleLyon.com (podcast, Strong Medical/Lifespan MD practice)
- BenGreenfieldLife.com / Google “Ben Greenfield”